181 related articles for article (PubMed ID: 6126286)
1. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
Holdstock G; Chastenay BF; Krawitt EL
Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
[TBL] [Abstract][Full Text] [Related]
2. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
Auer IO; Röder A; Fröhlich J
Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
[TBL] [Abstract][Full Text] [Related]
3. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.
Doering J; Begue B; Lentze MJ; Rieux-Laucat F; Goulet O; Schmitz J; Cerf-Bensussan N; Ruemmele FM
Gut; 2004 Nov; 53(11):1632-8. PubMed ID: 15479684
[TBL] [Abstract][Full Text] [Related]
4. Increased suppressor cell activity in inflammatory bowel disease.
Holdstock G; Chastenay BF; Krawitt EL
Gut; 1981 Dec; 22(12):1025-30. PubMed ID: 6119275
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Victorino RM
J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
[TBL] [Abstract][Full Text] [Related]
6. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
Comer SS; Jasin HE
J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
Stevens C; Lipman M; Fabry S; Moscovitch-Lopatin M; Almawi W; Keresztes S; Peppercorn MA; Strom TB
J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
[TBL] [Abstract][Full Text] [Related]
8. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
Goodacre RL; Bienenstock J
Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
[TBL] [Abstract][Full Text] [Related]
9. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
[TBL] [Abstract][Full Text] [Related]
10. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
11. Covert suppressor T cells in Crohn's disease.
Elson CO; Graeff AS; James SP; Strober W
Gastroenterology; 1981 Jun; 80(6):1513-21. PubMed ID: 6453036
[TBL] [Abstract][Full Text] [Related]
12. Immunological studies on Crohn's disease. II. Lack of evidence for humoral and cellular dysfunctions.
Fujita K; Okabe N; Yao T
J Clin Lab Immunol; 1985 Mar; 16(3):155-61. PubMed ID: 3162025
[TBL] [Abstract][Full Text] [Related]
13. Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease.
Elson CO; James SP; Graeff AS; Berendson RA; Strober W
Gastroenterology; 1984 Mar; 86(3):569-76. PubMed ID: 6229445
[TBL] [Abstract][Full Text] [Related]
14. Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
Dreyling KW; Hoppe U; Peskar BA; Schaarschmidt K; Peskar BM
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():339-43. PubMed ID: 2889333
[No Abstract] [Full Text] [Related]
15. Regulation of concanavalin A-activated suppressor cell activity by interferon.
Moidel RA; Schwartz SA; Schnitzer TJ
J Rheumatol; 1982; 9(5):665-70. PubMed ID: 6184473
[TBL] [Abstract][Full Text] [Related]
16. Concanavalin A induced suppressor activity exerted by peripheral blood mononuclear cells--with special reference to chronic inflammatory bowel disease.
Davidsen BD
Dan Med Bull; 1988 Jun; 35(3):201-22. PubMed ID: 2971513
[No Abstract] [Full Text] [Related]
17. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
Danis VA; Heatley RV
Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
Symmons DP; Salmon M; Farr M; Bacon PA
J Rheumatol; 1988 Apr; 15(4):575-9. PubMed ID: 2899645
[TBL] [Abstract][Full Text] [Related]
19. Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease.
Ginsburg CH; Falchuk ZM
Gastroenterology; 1982 Jul; 83(1 Pt 1):1-9. PubMed ID: 6210596
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of suppressor T cell activity by lymphocyte promoting factor of Bordetella pertussis.
Huang SW
Immunopharmacol Immunotoxicol; 1990; 12(1):61-76. PubMed ID: 2141034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
